Streptokinase is being successfully used as a thrombolytic agent for restoring the blood flow
following thromboembolism and myocardial infarction. However, high immunogenicity of the …

Streptokinase, a clot-dissolving agent, is widely used in treatment of cardiovascular
diseases such as blood clots and deep thrombosis. Streptokinase is a cost-effective drug …

Streptokinase is an efficient thrombolytic agent used to treat thromboembolic disorders.
Conventional streptokinase formulations have limited thrombolytic activity and several …

Streptokinase, as a thrombolytic drug, is widely used in treatment of cardiovascular
disorders and deep vein thrombosis. Streptokinase is immunogenic due to its prokaryotic …

Streptokinase (SK) is an effective thrombolytic agent, but it has a short half-life due to its
rapid elimination from the body. In this study, we prepared and evaluated polyethyleneglycol …

Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …

In this study, the enzyme streptokinase (thrombolysis agent) and chitosan (Cs) nanoparticles
were prepared by self-assembly. Using experimental design, chitosan concentration …

The objective of this work was to prepare the streptokinase (SK) entrapped in chitosan
nanoparticles (CS NPs) using bulk mixing (BM) and microfluidic (MF) techniques. The …

Vascular diseases leading to thrombo-occlusion are the leading cause of morbidity and
mortality worldwide. Revascularization and restoration of antegrade blood flow is critical for …

Acute thrombosis has a narrow therapeutic window and remains the leading cause of
morbidity and mortality, while thrombolytic therapy has limited efficacy and risk of side …